Prof. Dr. med. PhD MA MHI Paul Martin Putora
Leitender Arzt
Leitende(r) Arzt/Ärztin
Radio-Onkologie · Dept. IV
The Kafkaesque process of cancer diagnosis
Putora P, Oldenburg J. The Kafkaesque process of cancer diagnosis. J Clin Oncol 2014; 32:1087-8.
03.03.2014The Kafkaesque process of cancer diagnosis
03.03.2014J Clin Oncol 2014; 32:1087-8
Putora Paul Martin, Oldenburg Jan
Swarm-based medicine
Putora P, Oldenburg J. Swarm-based medicine. J Med Internet Res 2013; 15:e207.
19.09.2013Swarm-based medicine
19.09.2013J Med Internet Res 2013; 15:e207
Putora Paul Martin, Oldenburg Jan
Re-implantation after insufficient primary 125-i permanent prostate brachytherapy
Putora P, Plasswilm L, Seelentag W, Schiefer J, Markart P, Schmid H, Engeler D. Re-implantation after insufficient primary 125-i permanent prostate brachytherapy. Radiat Oncol 2013; 8:194.
06.08.2013Re-implantation after insufficient primary 125-i permanent prostate brachytherapy
06.08.2013Radiat Oncol 2013; 8:194
Putora Paul Martin, Plasswilm Ludwig, Seelentag Wolf, Schiefer Johann, Markart P, Schmid Hans-Peter, Engeler Daniel
Comorbidities and Burden of COPD: A Population Based Case-Control Study
Baty F, Putora P, Isenring B, Blum T, Brutsche M. Comorbidities and Burden of COPD: A Population Based Case-Control Study. PloS one 2013; 8:e63285.
17.05.2013Comorbidities and Burden of COPD: A Population Based Case-Control Study
17.05.2013PloS one 2013; 8:e63285
Baty Florent, Putora Paul Martin, Isenring Bruno, Blum Torsten, Brutsche Martin
FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma
Putora P, Früh M, Müller J. FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma. Respirology 2013; 18:734-5.
01.05.2013FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma
01.05.2013Respirology 2013; 18:734-5
Putora Paul Martin, Früh Martin, Müller Joachim
Relevance of incidental colorectal FDG-PET/CT-enhanced lesions
Putora P, Müller J, Borovicka J, Plasswilm L, Schmidt F. Relevance of incidental colorectal FDG-PET/CT-enhanced lesions. Onkologie 2013; 36:200-4.
18.03.2013Relevance of incidental colorectal FDG-PET/CT-enhanced lesions
18.03.2013Onkologie 2013; 36:200-4
Putora Paul Martin, Müller Joachim, Borovicka Jan, Plasswilm Ludwig, Schmidt Felix
Interdiziplinäre Therapie der Extremitäten Weichteil-Sarkome
Keller S, Putora P, Rothermundt C. Interdiziplinäre Therapie der Extremitäten Weichteil-Sarkome. info@onkologie 2013; 2:14-17.
14.02.2013Interdiziplinäre Therapie der Extremitäten Weichteil-Sarkome
14.02.2013info@onkologie 2013; 2:14-17
Keller S, Putora Paul Martin, Rothermundt Christian
Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas
Hundsberger T, Brügge D, Putora P, Weder P, Weber J, Plasswilm L. Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas. J Neurooncol 2013; 112:133-9.
12.01.2013Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas
12.01.2013J Neurooncol 2013; 112:133-9
Hundsberger Thomas, Brügge Detlef, Putora Paul Martin, Weder Patrik, Weber Johannes, Plasswilm Ludwig
Re-implantation after insufficient primary 125-I permanent prostate brachytherapy
Putora P, Plasswilm L, Seelentag W, Schiefer J, Markart P, Schmid H, Engeler D. Re-implantation after insufficient primary 125-I permanent prostate brachytherapy. Radiat Oncol 2013; 8:194.
01.01.2013Re-implantation after insufficient primary 125-I permanent prostate brachytherapy
01.01.2013Radiat Oncol 2013; 8:194
Putora Paul Martin, Plasswilm Ludwig, Seelentag Wolf, Schiefer Johann, Markart Patrick, Schmid Hans-Peter, Engeler Daniel
Compensability index for compensation radiotherapy after treatment interruptions
Putora P, Schmücking M, Aebersold D, Plasswilm L. Compensability index for compensation radiotherapy after treatment interruptions. Radiation Oncology 2012; 2012:208.
08.12.2012Compensability index for compensation radiotherapy after treatment interruptions
08.12.2012Radiation Oncology 2012; 2012:208
Putora Paul Martin, Schmücking Michael, Aebersold D, Plasswilm Ludwig
Compensability index for compensation radiotherapy after treatment interruptions
Putora P, Schmuecking M, Aebersold D, Plasswilm L. Compensability index for compensation radiotherapy after treatment interruptions. Radiat Oncol 2012; 7:208.
08.12.2012Compensability index for compensation radiotherapy after treatment interruptions
08.12.2012Radiat Oncol 2012; 7:208
Putora Paul Martin, Schmuecking Michael, Aebersold Daniel, Plasswilm Ludwig
Lokale palliative Therapieoptionen beim Prostatakarzinom
Schallegger K, Preusser S, Putora P. Lokale palliative Therapieoptionen beim Prostatakarzinom - Interdisziplinäres Vorgehen bei Schmerzen, infravesikaler Obstruktion, Blutung und therapiebedingten Nebenwirkungen. Schweizerische Zeitschrift für Onkologie 2012; 2012:33-36.
08.10.2012Lokale palliative Therapieoptionen beim Prostatakarzinom
08.10.2012Schweizerische Zeitschrift für Onkologie 2012; 2012:33-36
Schallegger Karin, Preusser Stefan, Putora Paul Martin
DESO St. Gallen, 2012: die Therapie des metastasierten Weichteilsarkoms im Erwachsenenalter
Rothermundt C, Putora P. DESO St. Gallen, 2012: die Therapie des metastasierten Weichteilsarkoms im Erwachsenenalter. Leading Opinions Hämatologie / Onkologie 2012; 2012:1-5.
03.05.2012DESO St. Gallen, 2012: die Therapie des metastasierten Weichteilsarkoms im Erwachsenenalter
03.05.2012Leading Opinions Hämatologie / Onkologie 2012; 2012:1-5
Rothermundt Christian, Putora Paul Martin
Palliative Systemtherapie des metastasierten Weichteil-Sarkoms
Cerny T, Rothermundt C, Putora P. Palliative Systemtherapie des metastasierten Weichteil-Sarkoms. info@onkologie 2012; 2012:6-9.
27.04.2012Palliative Systemtherapie des metastasierten Weichteil-Sarkoms
27.04.2012info@onkologie 2012; 2012:6-9
Cerny Thomas, Rothermundt Christian, Putora Paul Martin
Interdisziplinäre Therapie der Extremitäten-Weichteil-Sarkome
Keller S, Putora P, Rothermundt C. Interdisziplinäre Therapie der Extremitäten-Weichteil-Sarkome. info@onkologie 2012; 2012:10-13.
27.04.2012Interdisziplinäre Therapie der Extremitäten-Weichteil-Sarkome
27.04.2012info@onkologie 2012; 2012:10-13
Keller Stephan, Putora Paul Martin, Rothermundt Christian
Motion Artifacts and Implications of Different Window Levels in Contouring of Moving Targets
Duma M, Devecka M, Berndt J, Oechser M, Putora P (2012). Motion Artifacts and Implications of Different Window Levels in Contouring of Moving Targets.
19.04.2012Motion Artifacts and Implications of Different Window Levels in Contouring of Moving Targets
19.04.2012-
Duma MN, Devecka M, Berndt J, Oechser M, Putora Paul Martin
Good Reponse of Palliative Radiotherapy for Very Advanced Metastastic Melanoma
Horstkemper R, Putora P, Toepfer M, Plasswilm L (2012). Good Reponse of Palliative Radiotherapy for Very Advanced Metastastic Melanoma.
19.04.2012Good Reponse of Palliative Radiotherapy for Very Advanced Metastastic Melanoma
19.04.2012-
Horstkemper Ruth, Putora Paul Martin, Toepfer Michael, Plasswilm Ludwig
Manipulation and Quality Assurance of Guidelines; an Online Implementation of Diagnostic Nodes (Dodes)
Putora P, Horstkemper R, Papachristofilou A, Plasswilm L (2012). Manipulation and Quality Assurance of Guidelines; an Online Implementation of Diagnostic Nodes (Dodes).
19.04.2012Manipulation and Quality Assurance of Guidelines; an Online Implementation of Diagnostic Nodes (Dodes)
19.04.2012SASRO 2012
Putora Paul Martin, Horstkemper Ruth, Papachristofilou A, Plasswilm Ludwig
Radiotherapy with 3Gy for Inflammation due to Heterotopic Ossifications
Putora P, Horstkemper R, Müller J, Plasswilm L (2012). Radiotherapy with 3Gy for Inflammation due to Heterotopic Ossifications.
19.04.2012Radiotherapy with 3Gy for Inflammation due to Heterotopic Ossifications
19.04.2012SASRO 2012
Putora Paul Martin, Horstkemper Ruth, Müller Joachim, Plasswilm Ludwig
Customized Lung Phantom for Internal Target Volume Evaluation
Putora P, Fornaro J, Devecka M, Duma M, Plasswilm L (2012). Customized Lung Phantom for Internal Target Volume Evaluation.
19.04.2012Customized Lung Phantom for Internal Target Volume Evaluation
19.04.2012SASRO 2012
Putora Paul Martin, Fornaro Jürgen, Devecka M, Duma MN, Plasswilm Ludwig